Incheon, South Korea

Jun Hwan Kim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Osteoneurogen Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Hwan Kim. Retrieved from https://idiyas.com/inventor/jun-hwan-kim-jghz28nq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jun Hwan Kim in Fibrosis Treatment

Introduction

Jun Hwan Kim is an accomplished inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of fibrosis and non-alcoholic steatohepatitis. His innovative work has the potential to impact many lives positively.

Latest Patents

Jun Hwan Kim holds a patent for a compound represented by the following Formula 1 or a pharmaceutically acceptable salt thereof, titled "Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis." This patent highlights his dedication to developing effective treatments for serious health conditions. He has 1 patent to his name.

Career Highlights

Currently, Jun Hwan Kim is associated with Osteoneurogen Inc., where he continues to work on groundbreaking research and development. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Byung Soo Youn and Ho Sup Yoon. Their combined expertise contributes to the innovative environment at Osteoneurogen Inc.

Conclusion

Jun Hwan Kim's work in the pharmaceutical industry exemplifies the spirit of innovation and dedication to improving health outcomes. His contributions are paving the way for new treatments that could benefit many individuals suffering from fibrosis and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…